Aemetis, Inc.AMTXNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 71% recommend buying.

Consensus Rating

Buy

7 analysts·Limited coverage

71%

Rating Distribution

Strong Buy

00%

Buy

571%

Hold

114%

Sell

114%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 148% higher.

Bear Case

$3.50

+124%

Consensus

$3.88

+148%

Bull Case

$4.25

+172%

Price Range7 analysts

Low

Consensus

High

$3.50

$4.25

Current Target

Current Price

$1.56

Upside to Target

$2.31

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.62(3 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+14.48%

EPS—

FY2028

Rev+126.60%

EPS—

FY2029

Rev+11.56%

EPS+62.93%

Earnings Surprises

Beat rate:17%(2/12 quarters)

Avg surprise:-59.4%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jul 30, 2024Truist Financial

Aemetis (AMTX) PT Lowered to $3.50 at Truist Securities

Target:$3.50

+2.3%from $3.42

May 13, 2024Truist Financial

Aemetis (AMTX) PT Raised to $4 at Truist Securities

Target:$4.00

-1.5%from $4.06

Feb 1, 2023Truist Financial

Truist Securities Maintains Hold on Aemetis, Lowers Price Target to $5

Target:$5.00

+7.1%from $4.67

Dec 14, 2022UBS

UBS Initiates Coverage On Aemetis with Neutral Rating, Announces Price Target of $4.25

Target:$4.25

-4.1%from $4.43

Aug 8, 2022Truist Financial

Aemetis downgraded to Hold from Buy at Truist

Target:$12.00

+7.9%from $11.12

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance